JBIO- Jade Biosciences, Inc.

Name: Jade Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

JBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
Other	King Andrew James	386.1K	-	-
CEO	Frohlich Tom	86.3K	-	-
Dir	Eisner Mark	47.7K	-	-
CFO	Dahms Bradford D.	37.8K	-	-
Dir	Cain Christopher W.	34.8K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 11, 2022	Dake Benjamin T77	See Remarks	Sale+OE	21,998	$18.87	$415,084.94	-100%	+24.8%	-41.3%
Nov 8, 2022	Dake Benjamin T77	See Remarks	Sale+OE	26,000	$18.24	$474,351.34	-100%	+37.2%	-35.8%
Nov 7, 2022	Niven Ralph74	Chief Scientific Officer	Sale+OE	2,250	$19.20	$43,194.40	-58.3%	+40.0%	-31.5%
Nov 2, 2022	Verwijs Marinus82	Senior Vice President, Cmc	Sell	1,130	$18.89	$21,345.70	-100%	+20.4%	-41.6%
Nov 1, 2022	Noyes Timothy P81	Chief Executive Officer	Sell	1,038	$19.50	$20,241.00	-100%	+22.4%	-45.0%
Oct 18, 2022	Dake Benjamin T77	See Remarks	Sale+OE	5,705	$21.08	$120,286.50	-100%	+17.9%	-46.3%
Oct 17, 2022	Dake Benjamin T77	See Remarks	Sale+OE	4,295	$20.16	$86,585.14	-100%	+24.1%	-44.0%
Oct 10, 2022	Dake Benjamin T77	See Remarks	Sale+OE	4,954	$16.89	$83,681.06	-100%	+49.1%	-24.0%
Oct 7, 2022	Dake Benjamin T77	See Remarks	Sale+OE	23,560	$15.91	$374,803.40	-100%	+63.8%	-18.1%
Oct 5, 2022	Niven Ralph74	Chief Scientific Officer	Sale+OE	2,250	$15.75	$35,446.59	-58.3%	+63.9%	-17.3%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC